Martha Council, MD
MOHS-Micrographic Surgery · Saint Louis, MONPI 1245432244
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $31,756 of the $38,075 with a category attached, or 83.4%. 13 manufacturers reported payments, led by Sanofi at 37.0% of the total. Among mohs-micrographic surgery clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 105 payments — averaging $362.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$14K
- Regeneron Healthcare Solutions, Inc.$10K
- Regeneron$9K
- AbbVie$4K
- Galderma Laboratories, L.p.$293
- Incyte Corporation$128
- plus $478 from 7 others
Across 14 payments — averaging $2519.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$35K
What the payments were for
- Consulting fees$31,75683%
- Travel & lodging$2,6517%
- Food & beverage$3,66810%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 16 | $14,097 |
| Regeneron Healthcare Solutions, Inc. | 47 | $9,600 |
| Regeneron | 13 | $9,487 |
| AbbVie(2 entities) | 15 | $3,992 |
| Galderma Laboratories, L.p. | 4 | $293 |
| Incyte Corporation | 1 | $128 |
| Genentech USA, Inc. | 1 | $125 |
| UCB, Inc. | 1 | $124 |
| Dermavant Sciences, Inc. | 1 | $124 |
| Lilly USA, LLC | 3 | $55 |
| Kerecis Limited | 1 | $23 |
| Pfizer | 1 | $15 |
| Biofrontera Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$38,075 in reported general payments places this provider in the 90th percentile of 27 mohs-micrographic surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 11 | $784 |
| Clobetasol Propionate | 14 | $273 |
| Cephalexin | 61 | $233 |
| Doxycycline Hyclate | 17 | $207 |
| Mupirocin | 13 | $90 |
| Tramadol Hcl | 15 | $48 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Saint Louis
- Basia Michalski-McneelySaint Louis$12K
- Sino MehrmalSaint Louis$7K
- Ramona BehshadSaint Louis$3K
- Alexander AriaSaint Louis$3K
- Kelly WilmasSaint Louis$2K
- Lee PortnoffSaint Louis$283
- Mark KoryChesterfield$180K
- Ronald WheelandColumbia$109K
- Lindall PerryColumbia$11K
- Mark CohenKansas City$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.